The Arctic Front™ family of cryoballoons are approved in the United States to treat drug refractory, recurrent, symptomatic, paroxysmal and persistent atrial fibrillation (episode duration less than 6 months). The catheters have a proven safety and efficacy profile in treating AF.1Product Details
The Achieve™ and Achieve Advance™ Mapping Catheters are intra-cardiac electrophysiology diagnostic catheters designed for use with the Arctic Front™ family of cardiac cryoablation catheters, the FlexCath™ Advance Steerable Sheath and the CryoConsole™.Product Details
The Freezor™ family of cardiac cryoablation catheters are flexible, single-use, minimally invasive devices designed to ablate cardiac tissue. Used in conjunction with the CryoConsole, they are the only focal catheters that utilize the Cryo energy source, with ablation indications ranging from atrioventricular nodal reentry tachycardia (AVNRT) to atrial arrhythmias.Product Details
The CryoConsole houses the components and software needed to perform Cryoablation procedures with the Arctic Front™ family of cardiac cryoablation catheters or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.Product Details
The FlexCath Advance™ Steerable Sheath is part of the Arctic Front™ Cardiac Cryoablation Catheter System and is the only sheath that has been tested for use with the Arctic Front™ family of cardiac cryoablation catheters. It can also be used with the Freezor™ MAX Cardiac Cryoablation Catheter.Product Details
Packer DL, et al. J Am Coll Cardiol. 2013 Apr 23; 61(14):1713-1723.